CLINICAL_TRIALS
trial_result
· 2021-02-24
Clinical Trial Update: Study of TAK-228 (MLN0128) in Soft Tissue Sarcomas [Phase 2]
Summary
Phase 2 study of TAK-228 (MLN0128) in soft tissue sarcoma was terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fox Chase Cancer Center | Conditions: Soft-tissue Sarcoma | Phase 2 | Status: TERMINATED | Results posted: 2021-02-24